Literature DB >> 32876839

T1 and T2 MR fingerprinting measurements of prostate cancer and prostatitis correlate with deep learning-derived estimates of epithelium, lumen, and stromal composition on corresponding whole mount histopathology.

Rakesh Shiradkar1, Ananya Panda2,3, Patrick Leo4, Andrew Janowczyk4, Xavier Farre5, Nafiseh Janaki6,7, Lin Li4, Shivani Pahwa3, Amr Mahran8, Christina Buzzy8, Pingfu Fu9, Robin Elliott6, Gregory MacLennan6, Lee Ponsky8, Vikas Gulani3,10, Anant Madabhushi4.   

Abstract

OBJECTIVES: To explore the associations between T1 and T2 magnetic resonance fingerprinting (MRF) measurements and corresponding tissue compartment ratios (TCRs) on whole mount histopathology of prostate cancer (PCa) and prostatitis.
MATERIALS AND METHODS: A retrospective, IRB-approved, HIPAA-compliant cohort consisting of 14 PCa patients who underwent 3 T multiparametric MRI along with T1 and T2 MRF maps prior to radical prostatectomy was used. Correspondences between whole mount specimens and MRI and MRF were manually established. Prostatitis, PCa, and normal peripheral zone (PZ) regions of interest (ROIs) on pathology were segmented for TCRs of epithelium, lumen, and stroma using two U-net deep learning models. Corresponding ROIs were mapped to T2-weighted MRI (T2w), apparent diffusion coefficient (ADC), and T1 and T2 MRF maps. Their correlations with TCRs were computed using Pearson's correlation coefficient (R). Statistically significant differences in means were assessed using one-way ANOVA.
RESULTS: Statistically significant differences (p < 0.01) in means of TCRs and T1 and T2 MRF were observed between PCa, prostatitis, and normal PZ. A negative correlation was observed between T1 and T2 MRF and epithelium (R = - 0.38, - 0.44, p < 0.05) of PCa. T1 MRF was correlated in opposite directions with stroma of PCa and prostatitis (R = 0.35, - 0.44, p < 0.05). T2 MRF was positively correlated with lumen of PCa and prostatitis (R = 0.57, 0.46, p < 0.01). Mean T2 MRF showed significant differences (p < 0.01) between PCa and prostatitis across both transition zone (TZ) and PZ, while mean T1 MRF was significant (p = 0.02) in TZ.
CONCLUSION: Significant associations between MRF (T1 in the TZ and T2 in the PZ) and tissue compartments on corresponding histopathology were observed. KEY POINTS: • Mean T2 MRF measurements and ADC within cancerous regions of interest dropped with increasing ISUP prognostic groups (IPG). • Mean T1 and T2 MRF measurements were significantly different (p < 0.001) across IPGs, prostatitis, and normal peripheral zone (NPZ). • T2 MRF showed stronger correlations in the peripheral zone, while T1 MRF showed stronger correlations in the transition zone with histopathology for prostate cancer.

Entities:  

Keywords:  Deep learning; Magnetic resonance imaging; Prostatectomy; Prostatic neoplasms; Prostatitis

Mesh:

Year:  2020        PMID: 32876839      PMCID: PMC7882016          DOI: 10.1007/s00330-020-07214-9

Source DB:  PubMed          Journal:  Eur Radiol        ISSN: 0938-7994            Impact factor:   5.315


  32 in total

1.  On standardizing the MR image intensity scale.

Authors:  L G Nyúl; J K Udupa
Journal:  Magn Reson Med       Date:  1999-12       Impact factor: 4.668

2.  Multiparametric 3T prostate magnetic resonance imaging to detect cancer: histopathological correlation using prostatectomy specimens processed in customized magnetic resonance imaging based molds.

Authors:  Baris Turkbey; Haresh Mani; Vijay Shah; Ardeshir R Rastinehad; Marcelino Bernardo; Thomas Pohida; Yuxi Pang; Dagane Daar; Compton Benjamin; Yolanda L McKinney; Hari Trivedi; Celene Chua; Gennady Bratslavsky; Joanna H Shih; W Marston Linehan; Maria J Merino; Peter L Choyke; Peter A Pinto
Journal:  J Urol       Date:  2011-09-25       Impact factor: 7.450

Review 3.  Consensus development of a histopathological classification system for chronic prostatic inflammation.

Authors:  J C Nickel; L D True; J N Krieger; R E Berger; A H Boag; I D Young
Journal:  BJU Int       Date:  2001-06       Impact factor: 5.588

4.  Measurements of T(1) -relaxation in ex vivo prostate tissue at 132 μT.

Authors:  Sarah Busch; Michael Hatridge; Michael Mößle; Whittier Myers; Travis Wong; Michael Mück; Kevin Chew; Kyle Kuchinsky; Jeffry Simko; John Clarke
Journal:  Magn Reson Med       Date:  2012-01-31       Impact factor: 4.668

5.  Correlations between Apparent Diffusion Coefficient and Gleason Score in Prostate Cancer: A Systematic Review.

Authors:  Alexey Surov; Hans Jonas Meyer; Andreas Wienke
Journal:  Eur Urol Oncol       Date:  2019-01-23

6.  Magnetic resonance-invisible versus magnetic resonance-visible prostate cancer in active surveillance: a preliminary report on disease outcomes.

Authors:  Seyed Saeid Dianat; H Ballentine Carter; Kenneth J Pienta; Edward M Schaeffer; Patricia K Landis; Jonathan I Epstein; Bruce J Trock; Katarzyna J Macura
Journal:  Urology       Date:  2014-10-16       Impact factor: 2.649

7.  Radiomic features for prostate cancer detection on MRI differ between the transition and peripheral zones: Preliminary findings from a multi-institutional study.

Authors:  Shoshana B Ginsburg; Ahmad Algohary; Shivani Pahwa; Vikas Gulani; Lee Ponsky; Hannu J Aronen; Peter J Boström; Maret Böhm; Anne-Maree Haynes; Phillip Brenner; Warick Delprado; James Thompson; Marley Pulbrock; Pekka Taimen; Robert Villani; Phillip Stricker; Ardeshir R Rastinehad; Ivan Jambor; Anant Madabhushi
Journal:  J Magn Reson Imaging       Date:  2016-12-19       Impact factor: 4.813

8.  Patterns of inflammation in prostatic hyperplasia: a histologic and bacteriologic study.

Authors:  P W Kohnen; G W Drach
Journal:  J Urol       Date:  1979-06       Impact factor: 7.450

Review 9.  Benign Conditions That Mimic Prostate Carcinoma: MR Imaging Features with Histopathologic Correlation.

Authors:  Yu Xuan Kitzing; Adilson Prando; Celi Varol; Gregory S Karczmar; Fiona Maclean; Aytekin Oto
Journal:  Radiographics       Date:  2015-11-20       Impact factor: 5.333

10.  Magnetic resonance fingerprinting.

Authors:  Dan Ma; Vikas Gulani; Nicole Seiberlich; Kecheng Liu; Jeffrey L Sunshine; Jeffrey L Duerk; Mark A Griswold
Journal:  Nature       Date:  2013-03-14       Impact factor: 49.962

View more
  8 in total

1.  Magnetic resonance fingerprinting in prostate cancer before and after contrast enhancement.

Authors:  Young Sub Lee; Moon Hyung Choi; Young Joon Lee; Dongyeob Han; Dong-Hyun Kim
Journal:  Br J Radiol       Date:  2021-08-20       Impact factor: 3.039

2.  Repeatability of MR fingerprinting in normal cervix and utility in cervical carcinoma.

Authors:  Mandi Wang; Jose A U Perucho; Peng Cao; Varut Vardhanabhuti; Di Cui; Yiang Wang; Pek-Lan Khong; Edward S Hui; Elaine Y P Lee
Journal:  Quant Imaging Med Surg       Date:  2021-09

3.  ITHscore: comprehensive quantification of intra-tumor heterogeneity in NSCLC by multi-scale radiomic features.

Authors:  Jiaqi Li; Zhenbin Qiu; Chao Zhang; Sijie Chen; Mengmin Wang; Qiuchen Meng; Haiming Lu; Lei Wei; Hairong Lv; Wenzhao Zhong; Xuegong Zhang
Journal:  Eur Radiol       Date:  2022-08-24       Impact factor: 7.034

Review 4.  Role of Deep Learning in Prostate Cancer Management: Past, Present and Future Based on a Comprehensive Literature Review.

Authors:  Nithesh Naik; Theodoros Tokas; Dasharathraj K Shetty; B M Zeeshan Hameed; Sarthak Shastri; Milap J Shah; Sufyan Ibrahim; Bhavan Prasad Rai; Piotr Chłosta; Bhaskar K Somani
Journal:  J Clin Med       Date:  2022-06-21       Impact factor: 4.964

Review 5.  MR fingerprinting of the prostate.

Authors:  Wei-Ching Lo; Ananya Panda; Yun Jiang; James Ahad; Vikas Gulani; Nicole Seiberlich
Journal:  MAGMA       Date:  2022-04-13       Impact factor: 2.533

6.  Integrating pathomics with radiomics and genomics for cancer prognosis: A brief review.

Authors:  Cheng Lu; Rakesh Shiradkar; Zaiyi Liu
Journal:  Chin J Cancer Res       Date:  2021-10-31       Impact factor: 4.026

7.  Infiltrative growth pattern of prostate cancer is associated with lower uptake on PSMA PET and reduced diffusion restriction on mpMRI.

Authors:  Riccardo Laudicella; Jan H Rüschoff; Niels J Rupp; Irene A Burger; Daniela A Ferraro; Muriel D Brada; Daniel Hausmann; Iliana Mebert; Alexander Maurer; Thomas Hermanns; Daniel Eberli
Journal:  Eur J Nucl Med Mol Imaging       Date:  2022-04-18       Impact factor: 10.057

8.  Comparison of single-shot EPI and multi-shot EPI in prostate DWI at 3.0 T.

Authors:  Tsutomu Tamada; Ayumu Kido; Yu Ueda; Mitsuru Takeuchi; Akihiko Kanki; Jaladhar Neelavalli; Akira Yamamoto
Journal:  Sci Rep       Date:  2022-09-27       Impact factor: 4.996

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.